HealthLinx's OvPlex Test Posts Weak Sales Numbers Despite Year of Big Distribution Gains

With its recent deal for South Korean distribution, the company has agreements for OvPlex in the UK, Australia, Singapore, Israel, and South Korea, but sales of the test still lag well behind expectations.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.